Fierce Pharma August 22, 2023
By Fraiser Kansteiner

The “fundamental problem” with drug shortages, to hear FDA Commissioner Robert Califf tell it, is that “we essentially have two drug industries in the U.S.” (Matthew MacRoberts/FDA)

Robert Califf, M.D., is “fired up” about the spate of U.S. drug shortages that now constitutes a “national security threat,” the FDA commissioner said Tuesday.

“I did not come back to FDA to spend all my time on supply chain, but that’s what’s happened,” Califf said in response to a question about shortages during a recent presentation of the Alliance for a Stronger FDA. “And I feel like I know a lot about it, and I’m pretty fired up to do something about it.”

Countless therapeutics, from ADHD meds and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
Key Trends in the Evolution of PBMs and Their Future Impact on Drug Pricing and Pharmacy Operations

Share This Article